3
Shared Docs
3
Same-Page
3 / 3
Mentions
Deutsche Bank Markets Research Rating Company Date Buy Aegerion Alert 18 November 2013 Company Update North America United States Nice at 15 Nov 2013 (USD) 74.73 Health Care AEGR.00 AEGR UO NMS AEGR Nice !swot 115.00 Biotechnology 52-week range 97.24 -
nt for those years. The co would be increasing sales force substantially in 2014 instead of increasing sales force every year. Before the launch of Juxtapid, the co guided for 15 sales reps in the US. We believe the number is higher now and is expected to increase. Focus on customer care to help with pr
Deutsche Bank Markets Research Rating Company Date Buy Aegerion Alert 18 November 2013 Company Update North America United States Price at 15 Nov 2013 (USD) 74.73 Health Care AEGR.00 AEGR UO NMS AEGR Nice tweet 115.00 Biotechnology 52-week range 97.24
nt for those years. The co would be increasing sales force substantially in 2014 instead of increasing sales force every year. Before the launch of Juxtapid, the co guided for 15 sales reps in the US. We believe the number is higher now and is expected to increase. Focus on customer care to help with pr
Deutsche Bank Markets Research Rating Buy Company Aegerion Alert North America United States (:( I' Health Care AEGR.0O AEGR UO NMS AEGR Biotechnology Update post speaking with Management We spoke to AEGR management
nt for those years. The co would be increasing sales force substantially in 2014 instead of increasing sales force every year. Before the launch of Juxtapid, the co guided for 15 sales reps in the US. We believe the number is higher now and is expected to increase. Focus on customer care to help with pr
Entities connected to both North America and Juxtapid